J8 it will be interesting to see whether the FDA has any questions regarding BLT's IND for TT-034. If no questions, then it goes straight into clinical trial on Jan 5.
The CEO certainly has visions of grandeur. Check it out:
http://www.theaustralian.com.au/national-affairs/biotech-firm-offers-remedy-for-carmaker-void/story-fn59niix-1226786216918#
